Henit Yanai
Appearances
- DateMay 9, 2023BACKGROUND: Biological treatment in inflammatory bowel disease (IBD) patients is currently hampered by high non-response rates. To enhance personalized medicine and predict response to biological therapeutics such as vedolizumab, the working mechanism should be elucidated…
Presenter
Speakers
- DateMay 18, 2024BACKGROUND: Early detection of inflammatory flares and corresponding treatment adjustment were shown to improve inflammatory bowel disease (IBD) patient care. Current episodic inflammatory biomarker testing allows limited monitoring and is associated with suboptimal compliance…
Presenter
Speakers
Tel Aviv Sourasky Medical Center - DateMay 20, 2024Background: Optimal strategies for treat-to-target in Crohn’s disease (CD) are still being sought. We aimed to examine the value of capsule endoscopy (CE) to guide proactive treatment optimization in patients with CD…
- DateMay 18, 2024BACKGROUND: The Mediterranean diet (MED) is hypothesized to play a protective role in Crohn’s disease (CD) etiology, yet the underlying mechanisms remain unclear…
Presenter
Speakers
Tel Aviv Sourasky Medical Center